Companies /Consumer Cyclical

Starbucks Corp

NASDAQ: SBUX Restaurants
$91.62
▼ $0.66 (−0.72%) today
Markets open · 2:23pm ET

SBUX Coverage Page 21

8:13am ET
Companies and Brands

Nestle Adds Peanut Allergy Treatment to Its Portfolio

Consumer products giant Nestlé has agreed to acquire Aimmune Therapeutics, maker of a peanut-allergy treatment. The deal is valued at $2.6 billion, including Nestlé's existing stake Aimmune.

Paul Ausick